Notably, immune checkpoint inhibitors stimulate cytotoxic T cell proliferation, while SERPING1 overexpression diminishes Myeloid-Derived Suppressor Cells (MDSCs) infiltration in the tumor microenvironment, alleviates MDSC-induced T cell suppression, and enhances overall T cell function. Here, SERPING1 is linked to neoplasm.